Recommended Checks and Screenings for Well-Child Visits in Children with Down Syndrome
Children with Down syndrome require comprehensive and specialized screening at well-child visits beyond standard pediatric care to monitor for common comorbidities and developmental issues specific to this population. These children should be considered high-risk for developmental disorders and require more intensive monitoring and earlier intervention.
Core Screenings for All Well-Child Visits
- Growth parameters: Plot on Down syndrome-specific growth charts
- Developmental surveillance: Assess motor, language, social, and adaptive skills at each visit
- Behavioral screening: Use age-appropriate screening tools to identify common behavioral issues
- Thyroid function tests: Higher adherence to thyroid screening (61%) has been reported when performed by pediatricians 1
- Complete blood count: To monitor for leukemia and other hematologic abnormalities (55% adherence reported) 1
Age-Specific Screenings
Infancy (Birth to 12 months)
- Cardiac evaluation: Echocardiogram for all infants with Down syndrome
- Hearing screening: Newborn hearing test and follow-up at 6 months
- Vision assessment: Red reflex examination, external inspection of eyes, and ocular motility assessment 2
- Cervical spine radiographs: To assess for atlantoaxial instability (94% adherence reported) 1
- Developmental screening: At 9-month visit, assess if infant can roll to both sides, sit without support, and demonstrate motor symmetry 2
Early Childhood (1-3 years)
- Vision screening: Complete ophthalmologic examination by 12 months
- Hearing evaluation: Audiologic assessment every 6 months until age 3
- Thyroid function tests: Annual TSH and free T4
- Sleep study: By age 4 or sooner if symptoms of sleep apnea present
- Developmental screening: At 18-month visit, verify if toddler sits, stands, walks independently, and manipulates small objects 2
- Autism-specific screening: At 18 and 24 months as recommended by AAP 2
Middle Childhood (4-10 years)
- Vision assessment: Annual ophthalmologic examination
- Hearing evaluation: Annual audiologic assessment
- Thyroid function tests: Annual TSH and free T4
- Celiac disease screening: Consider testing if symptoms present
- Developmental assessment: At 48-month visit, assess fine motor, handwriting, gross motor, communication, and feeding abilities 2
- Behavioral screening: Use Pediatric Symptom Checklist or Strengths and Difficulties Questionnaire 2
Adolescence (11-21 years)
- Thyroid function tests: Continue annual screening
- Cervical spine assessment: Before participation in sports
- Hearing and vision: Continue annual evaluations
- Sexual development: Provide appropriate anticipatory guidance
- Psychosocial adjustment: Screen for mental health concerns using multiple informants including adolescents themselves, parents, and teachers 2
Special Considerations
Developmental Evaluation
Children with Down syndrome should be considered high-risk for developmental disorders and require:
- Direct referral for formal developmental evaluation at key ages: 12-24 months, 3-5 years, and 11-12 years 2
- Early intervention services before confirmation of specific developmental disorders 2
- Multidisciplinary team approach for comprehensive evaluation 2
Common Pitfalls to Avoid
- Inadequate screening frequency: Studies show adherence to recommended screenings is suboptimal, particularly for audiology (33%) and ophthalmology (43%) 1
- Missing atlantoaxial instability guidance: Anticipatory guidance regarding atlantoaxial instability has low adherence (<35%) 3
- Overlooking behavioral/mental health: Children with intellectual disability have psychiatric disorders at least three times more often than typically developing children 2
- Age-related decline in adherence: Overall adherence to guidelines is higher when a child is younger 3
- Provider variation: Adherence is higher when care is provided by attending-level pediatricians versus other providers 3
By implementing these comprehensive screenings at well-child visits, healthcare providers can significantly improve early detection of common comorbidities and developmental issues in children with Down syndrome, leading to better health outcomes and quality of life.